MedPath

StUdy oN Burst Fractures (SunBurst)

Not Applicable
Active, not recruiting
Conditions
Thoracolumbar Burst Fracture
Interventions
Procedure: Surgical stabilization
Registration Number
NCT05003180
Lead Sponsor
Uppsala University
Brief Summary

Thoracolumbar (TL) burst fractures are seen in all ages and usually associated with high-energy trauma. Treatment include both surgical and non-surgical options. In cases without neurological deficit or definite rupture of the posterior ligament complex (PLC) both surgical treatment and non-surgical treatment are considered standard of care. This study aims to compare outcome between surgical and non-surgical in patients with a single level TL burst fracture (AO A3/4) in a randomized controlled trial (RCT).

Detailed Description

The study is an international, multicenter, randomized controlled trial. 202 patients with a single level TL burst fracture will be enrolled in the study. They will be randomized 1:1 to either surgery with posterior fixation or non-surgical treatment. The study is pragmatical in its approach, i.e., the treating physician can decide on details of the surgical treatment as well as details of the non-surgical treatment. In non-surgically treated patients brace treatment is not required, but a hyperextension brace may be offered. The subjects will be followed with patient reported outcomes, clinical assessments, and radiological assessments. Data will be collected from questionnaires, patient files or national registers to compare sick leave, medical complications, pharmaceutical prescriptions and overall costs for each treatment.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
202
Inclusion Criteria
  • A single level thoracolumbar (Th10-L3) burst fracture, A3 or A4, according to the AO Spine classification
  • Aged 18-66 years
  • Informed consent
  • Acute injury with diagnosis and treatment within 2 weeks
  • May have minor fractures in adjacent vertebras if these fractures in themselves would not have resulted in any treatment
  • May have a single nerve root injury
Exclusion Criteria
  • Unable to consent, no consent given or not informed
  • Neurological injury involving more than a single level root, i.e., spinal cord and/or cauda equina injury
  • Definite rupture of the posterior tension band (through bony and/or ligamentous structures) verified on MRI
  • Patients with ankylosing spinal disorders spanning the fracture area
  • Prior spinal surgeries within the fractured area
  • Open vertebral fracture
  • Additional injury which would impair early ambulation, e.g., long bone fractures, severe head injury, long-lasting intensive care
  • Patients not deemed suitable due to severe co-morbidities. (E.g., established osteoporosis that would impair the possibility to maintain integrity of spinal implants, pathological fractures, severe cardiac or pulmonary compromise, or other systemic disease that would result in such high anesthesiologic risk that surgery would not be attempted.)
  • Patients already included in the study cannot be randomized again if they get an additional spine fracture

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SurgicalSurgical stabilizationSurgical stabilization. Brace treatment will not be used postoperative. Early ambulation after surgery is encouraged. Surgery is to be performed within 2 weeks from the injury. The choice of supplier and brand of implants are based on the preference of each participating center. Physiotherapy and other measures of rehabilitation are prescribed on an individual basis.
Primary Outcome Measures
NameTimeMethod
Group difference in Oswestry Disability Index (ODI) 1 year after the fracture.At 1 year after the fracture

ODI is a patient-reported outcome measure for spinal disorders. It consists of 10 questions related to back specific disabilities such as pain, personal care, walking and sitting ability, lifting capacity and social life.

Secondary Outcome Measures
NameTimeMethod
Social cost at 10 yearsAt 10 years after the fracture.

Analysis of the long-term social cost will be calculated for each treatment by collecting data on cost from sick leave from the Social Insurance Agency, estimated cost from health care visits collected from the National Patient Register and estimated cost on pharmaceutical prescriptions from the Prescribed Drug Register at 10 years. In Norway similar data will be collected from patient files and questionnaires.

Change in Oswestry Disability Index (ODI) from the time of the fracture to 1 year after the fractureAt the time of the fracture and 1 year after the fracture.

Change in ODI between groups.

Change in Oswestry Disability Index (ODI) from the time of the fracture to 3 to 4 months after the fractureAt the time of the fracture and 3 to 4 months after the fracture.

Change in ODI between groups.

Change in Short Musculoskeletal Function Assessment (SMFA) from the time of the fracture to 3 to 4 months after the fractureAt the time of the fracture and 3 to 4 months after the fracture.

Change in SMFA between groups.

Change in Short Musculoskeletal Function Assessment (SMFA) from the time of the fracture to 1 year after the fractureAt the time of the fracture and 1 year after the fracture.

Change in SMFA between groups.

Group difference in EQ-5D-5L at 3 to 4 monthsAt 3 to 4 months after the fracture.

EQ-5D-5L is a standardized quality of life instrument developed by the EuroQol group. It consists of 5 dimensions measuring mobility, personal care, usual activities, pain/discomfort and anxiety/depression with 5 levels for each dimension (1=no problems, 2=slight problems, 3=moderate problems, 4=severe problems, 5=extreme problems). It also has a visual analog scale (EQ VAS) from 0 (worst possible health) to 100 (best possible health) to measure how the subjects consider their own health.

Change in EQ-5D-5L from the time of the fracture to 1 year after the fractureAt the time of the fracture and 1 year after the fracture.

Change in EQ-5D-5L between groups.

Change in radiographic pattern- supine computed tomography - from the time of fracture to 3 to 4 monthsFrom the time of fracture to 3 to 4 months after the fracture.

The patients will do a computed tomography (CT). The degree of fracture compression, local and global kyphosis and adjacent segment degeneration will be registered. Group comparisons of radiological changes will be performed.

Adverse events1 year after last subject recruitment

The subjects will be linked with The National Board of Health and Welfare National Patient Register by using their Swedish personal identity number (PIN). Data on the level of inpatient and outpatient healthcare, spinal surgery during follow up and adverse events (i.e., postoperative infections, thromboembolism, etc.) will be collected and compared between the study groups. In Norway similar data will be collected from the patient files and questionnaires.

Group difference in radiographic pattern- supine computed tomography at 3 to 4 monthsAt 3 to 4 months after the fracture.

The patients will do a computed tomography (CT) at 3 to 4 months after the fracture. The degree of fracture compression, local and global kyphosis and adjacent segment degeneration will be compared.

Magnetic resonance imaging (MRI) at 1 yearAt 1 year after the fracture.

The patients will do a magnetic resonance imaging (MRI). The degree of fracture compression, local and global kyphosis, adjacent segment degeneration and extent of any soft tissue injuries will be registered. Group comparisons of MRI changes will be performed.

Imaging in correlation to patient reported outcome measures at 1 year from the fractureAt 1 year after the fracture.

The degree of fracture compression, local and global kyphosis, adjacent segment degeneration and extent of any soft tissue injuries registered on X-ray, CT and MRI will be compared to patient reported outcome measures at 1 year.

Group difference in Short Musculoskeletal Function Assessment (SMFA) at 3 to 4 monthsAt 3 to 4 months after the fracture.

SMFA is a patient-reported outcome measure for a broad range of musculoskeletal disorders consisting of a total of 46 questions. 34 questions measure the patient's dysfunction and 12 questions measure how bothered the patients are by their symptoms.

Group difference in EQ-5D-5L at 1 yearAt 1 year after the fracture.

EQ-5D-5L is a standardized quality of life instrument developed by the EuroQol group. It consists of 5 dimensions measuring mobility, personal care, usual activities, pain/discomfort and anxiety/depression with 5 levels for each dimension (1=no problems, 2=slight problems, 3=moderate problems, 4=severe problems, 5=extreme problems). It also has a visual analog scale (EQ VAS) from 0 (worst possible health) to 100 (best possible health) to measure how the subjects consider their own health.

Group difference in radiographic fracture pattern- standing radiographAt 1 year after the fracture.

The patients will do a standing, whole spine radiograph. The degree of fracture compression, local and global kyphosis will be registered.

Short Musculoskeletal Function Assessment (SMFA) at 10 yearsAt10 years after the fracture.

SMFA are planned to be collected after 10 years.

EQ-5D-5L at 10 yearsAt10 years after the fracture.

EQ-5D-5L are planned to be collected after 10 years.

Group difference in Oswestry Disability Index (ODI) 3 to 4 months after the fractureAt 3 to 4 months after the fracture.

ODI is a patient-reported outcome measure for spinal disorders. It consists of 10 questions related to back specific disabilities such as pain, personal care, walking and sitting ability, lifting capacity and social life.

Group difference in radiographic pattern- supine computed tomography at 1 yearAt 1 year after the fracture.

The patients will do a computed tomography (CT) 1 year after the fracture. The degree of fracture compression, local and global kyphosis and adjacent segment degeneration will be compared.

Drug prescription/consumption1 year after last subject recruitment

Data on analgesics and antibiotics prescribed will be collected from The National Board of Health and Welfare Swedish Prescribed Drug Register. Collected prescriptions will be assessed as dichotomous data (collected/not collected) at different time intervals; 0 to 4 months and 4 months to 1 year. In Norway similar data will be collected from the patient files and questionnaires.

Sick leave1 year after last subject recruitment

Data from the Swedish Social Insurance Agency / Statistics Sweden will be collected to compare sick leave and loss of income due to the fracture. Data will be stratified based on the presence or absence of sick leave before the fracture event. Data on total time on sick leave as well as the diagnosis used for sick leave will be collected. In Norway similar data will be collected from the patient files and questionnaires.

Individual cost from the time of fracture to 1 yearFrom the time of fracture to 1 year after the fracture.

The number of outpatient and telephone contacts (physician, nurse, physiotherapist) and salary losses the fracture and treatment have resulted in will be collected from patient files and official health registries and compared between the groups.

Sick leave at 10 yearsAt 10 years after the fracture.

Long-term data on sick leave are to be collected from the Social Insurance Agency at 10 years to compare difference in long-term sick leave between study groups. In Norway similar data will be collected from patient files and questionnaires.

Mortality at 1 year1 year after last subject recruitment

Mortality, including the cause of death, will be collected from the National Board of Health and Welfare Cause of Death Register. In Norway data will be collected from official registries.

Mortality at 5 year5 years after last subject recruitment

Mortality, including the cause of death, will be collected from the National Board of Health and Welfare Cause of Death Register. In Norway data will be collected from official registries.

Group difference in Short Musculoskeletal Function Assessment (SMFA) at 1 yearAt 1 year after the fracture.

SMFA is a patient-reported outcome measure for a broad range of musculoskeletal disorders consisting of a total of 46 questions. 34 questions measure the patient's dysfunction and 12 questions measure how bothered the patients are by their symptoms.

Change in EQ-5D-5L from the time of the fracture to 3 to 4 months after the fractureAt the time of the fracture and 3 to 4 months after the fracture.

Change in EQ-5D-5L between groups.

Change in radiographic pattern- supine computed tomography - from 3 to 4 months to 1 year from the fractureFrom 3 to 4 months to 1 year from the fracture after the fracture.

The patients will do a computed tomography (CT). The degree of fracture compression, local and global kyphosis and adjacent segment degeneration will be registered. Group comparisons of radiological changes will be performed.

Change in radiographic pattern- supine computed tomography - from the time of fracture to 1 yearFrom the time of fracture to 1 year after the fracture.

The patients will do a computed tomography (CT). The degree of fracture compression, local and global kyphosis and adjacent segment degeneration will be registered. Group comparisons of radiological changes will be performed.

Imaging in correlation to patient reported outcome measures at 3 to 4 months from the fractureAt 3 to 4 months from the fracture

The degree of fracture compression, local and global kyphosis, adjacent segment degeneration and extent of any soft tissue injuries registered on computed tomography (CT) will be compared to patient reported outcome measures at 3 to 4 months

Individual cost from the time of fracture to 3 to 4 monthsFrom the time of fracture to 3 to 4 months after the fracture.

The number of outpatient and telephone contacts (physician, nurse, physiotherapist) and salary losses the fracture and treatment have resulted in will be collected from patient files and official health registries and compared between the groups.

Social cost at 5 yearsAt 5 years after the fracture.

Analysis of the long-term social cost will be calculated for each treatment by collecting data on cost from sick leave from the Social Insurance Agency, estimated cost from health care visits collected from the National Patient Register and estimated cost on pharmaceutical prescriptions from the Prescribed Drug Register at 5 years. In Norway similar data will be collected from patient files and questionnaires.

Incremental cost-effectiveness ratio1 year after last subject recruitment

Quality-adjusted life years (QALYs) will be calculated for each group as measured by EQ-5D-5L. Combining cost and QALY yields the incremental cost-effectiveness ratio (ICER) of the surgical intervention as compared to non-surgical care.

Short Musculoskeletal Function Assessment (SMFA) at 5 yearsAt 5 years after the fracture.

SMFA are planned to be collected after 5 years.

Mortality at 10 years10 years after last subject recruitment

Mortality, including the cause of death, will be collected from the National Board of Health and Welfare Cause of Death Register. In Norway data will be collected from official registries.

Oswestry Disability index (ODI) at 5 yearsAt 5 years after the fracture.

ODI are planned to be collected at 5 years.

Oswestry Disability index (ODI) at 10 yearsAt 10 years after the fracture.

ODI are planned to be collected at 10 years.

EQ-5D-5L at 5 yearsAt 5 years after the fracture.

EQ-5D-5L are planned to be collected after 5 years.

Sick leave at 5 yearsAt 5 years after the fracture.

Long-term data on sick leave are to be collected from the Social Insurance Agency at 5 years to compare difference in long-term sick leave between study groups. In Norway similar data will be collected from patient files and questionnaires.

Trial Locations

Locations (17)

Haukeland University Hospital

🇳🇴

Bergen, Norway

Akershus University Hospital

🇳🇴

Oslo, Norway

Oslo University Hospital

🇳🇴

Oslo, Norway

Stavanger University Hospital

🇳🇴

Stavanger, Norway

St. Olavs Hospital

🇳🇴

Trondheim, Norway

Sahlgrenska University Hospital

🇸🇪

Gothenburg, Sweden

Halmstad Hospital

🇸🇪

Halmstad, Sweden

Ryhov Hospital

🇸🇪

Jönköping, Sweden

Kalmar Hospital

🇸🇪

Kalmar, Sweden

Linköping University Hospital

🇸🇪

Linköping, Sweden

Skåne University Hospital

🇸🇪

Malmö, Sweden

Karolinska University Hospital

🇸🇪

Stockholm, Sweden

Stockholm South General Hospital

🇸🇪

Stockholm, Sweden

University Hospital of Umeå

🇸🇪

Umeå, Sweden

Uppsala University Hospital

🇸🇪

Uppsala, Sweden

Central Hospital of Västerås

🇸🇪

Västerås, Sweden

Örebro University Hospital

🇸🇪

Örebro, Sweden

© Copyright 2025. All Rights Reserved by MedPath